NCT01520727View on ClinicalTrials.gov

A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2009

Conditions
Parkinson Disease
Interventions
DRUG

BIA 9-1067

single ascending doses in up to 8 sequential groups of 8 healthy young male subjects

DRUG

Placebo

single-dose

Trial Locations (1)

F-35000

BIOTRIAL, Rennes

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT01520727 - A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter